News

Molecular Diagnostics for Ambiguous Melanocytic Tumors

his review discusses the development of and advances in molecular techniques, including comparative genomic hybridization and fluorescence in situ hybridization (FISH) as diagnostic and prognostic tools for melanocytic neoplasms.


 

Hilmy Shahbain, BS, Chelsea Cooper, BA, and Pedram Gerami, MD

Certain subsets of melanocytic neoplasms are difficult to classify because of conflicting histologic features and the existence of a poorly defined intermediate grade of melanocytic tumors. The integration of molecular diagnostic information with a histologic impression may contribute significantly toward improving classification. This review discusses the development of and advances in molecular techniques, including comparative genomic hybridization and fluorescence in situ hybridization (FISH) as diagnostic and prognostic tools for melanocytic neoplasms. Further, we discuss how specific molecular aberrations identified via FISH correlate with certain morphologies in melanocytic neoplasms. We also examine the prognostic value of FISH in intermediate-grade melanocytic tumors, particularly atypical Spitz tumors.

*For a PDF of the full article, click on the link to the left of this introduction.

Recommended Reading

Health Care Professionals Tank in Cancer Survey
MDedge Dermatology
More Evidence Links Tanning Beds to Skin Cancer
MDedge Dermatology
Cutaneous Oncology, Pruritus Top Derm Research Agenda
MDedge Dermatology
Tanning Bed Risks Not Communicated to 73% of Germans
MDedge Dermatology
Imaging Unwarranted in Primary Cutaneous Melanoma
MDedge Dermatology
Merkel Cell Carcinoma Prognosis Linked to Vitamin D
MDedge Dermatology
Melanoma Treatment With Vemurafenib Can Trigger Leukemia
MDedge Dermatology
Innovative Methods of UV Protection
MDedge Dermatology
There's No Place for 'Dabbling' in Mohs Surgery
MDedge Dermatology
Broad-Spectrum Moisturizer Effectively Prevents Molecular Reactions to UVA Radiation
MDedge Dermatology